Clinical Trial: A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07715305) titled 'A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers' on July 15.

Brief Summary: The study compare and evaluate the bioequivalence between the administration of AD-116A and the administration of AD-1161 in healthy adult male volunteers

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Benign Prostatic Hyperplasia

Intervention: DRUG: AD-116A

Oral Capsule

DRUG: AD-1161

Oral Capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....